Angiotensin-converting enzyme inhibitors - the risk of dementia and possibilities of improving cognitive functions:the unique characteristics of perindopril
- Authors: Ostroumova O.D1,2, Galeeva N.Y.1, Bondarets O.V1, Guseva T.F1, Kopchenov I.I1
-
Affiliations:
- A.I.Evdokimov Moscow State Medical and Dental University of the Ministry of Health of the Russian Federation
- I.M.Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation
- Issue: Vol 18, No 1 (2016)
- Pages: 67-72
- Section: Articles
- URL: https://journals.rcsi.science/2075-1753/article/view/94402
- ID: 94402
Cite item
Full Text
Abstract
Full Text
##article.viewOnOriginalSite##About the authors
O. D Ostroumova
A.I.Evdokimov Moscow State Medical and Dental University of the Ministry of Health of the Russian Federation; I.M.Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation
Email: ostroumova.olga@mail.ru
д-р мед. наук, проф. каф. факультетской терапии и профболезней ГБОУ ВПО МГМСУ им. А.И.Евдокимова, проф. каф. клинической фармакологии и профболезней ГБОУ ВПО Первый МГМУ им. И.М.Сеченова 127473, Russian Federation, Moscow, ul. Delegatskaia, d. 20, str. 1
N. Yu Galeeva
A.I.Evdokimov Moscow State Medical and Dental University of the Ministry of Health of the Russian Federationсоискатель каф. факультетской терапии и профболезней ГБОУ ВПО МГМСУ им. А.И.Евдокимова 127473, Russian Federation, Moscow, ul. Delegatskaia, d. 20, str. 1
O. V Bondarets
A.I.Evdokimov Moscow State Medical and Dental University of the Ministry of Health of the Russian Federationканд. мед. наук, доц. каф. факультетской терапии и профболезней ГБОУ ВПО МГМСУ им. А.И.Евдокимова 127473, Russian Federation, Moscow, ul. Delegatskaia, d. 20, str. 1
T. F Guseva
A.I.Evdokimov Moscow State Medical and Dental University of the Ministry of Health of the Russian Federationканд. мед. наук, доц. каф. факультетской терапии и профболезней ГБОУ ВПО МГМСУ им. А.И.Евдокимова 127473, Russian Federation, Moscow, ul. Delegatskaia, d. 20, str. 1
I. I Kopchenov
A.I.Evdokimov Moscow State Medical and Dental University of the Ministry of Health of the Russian Federationканд. мед. наук, доц. каф. факультетской терапии и профболезней ГБОУ ВПО МГМСУ им. А.И.Евдокимова 127473, Russian Federation, Moscow, ul. Delegatskaia, d. 20, str. 1
References
- Захаров В.В., Локшина А.Б. Когнитивные нарушения в общеклинической практике. М., 2009.
- Larrieu S, Letenneur L, Orgogozo J.M. Incidence and outcome of mild cognitive impairment in a population - based prospective cohort. Neurology 2002; 59: 1594-9.
- Левин О.С. Диагностика и лечение деменции в клинической практике. М.: МЕДпресс - информ, 2010.
- Диагностика и лечение артериальной гипертензии // Системные гипертензии. 2010; 6 (3): 5-26.
- Henderson A.S. Dementia. World Health Organization, Geneva, 1994.
- Amaducci L, Andrea L. The epidemiology of the dementia in Europe. In: A.Culebras, J.Matias Cuiu, G.Roman (eds): New concepts in vascular dementia. Barselona: Prous Science Publishers, 1993; p. 1927.
- Skoog I, Lernfelt B, Landahl S et al. 15-years longitudinal study of blood pressure and dementia. Lancet 1996; 347: 1141-5.
- Launer L.J, Masaki K, Petrovitch H et al. The assotiation between midlife blood pressure levels and late - life cognitive function. The Honolulu-Asia Aging Study. JAMA 1995; 274: 1846-51.
- Singh-Manoux A, Marmot M. High blood pressure was associated with cognitive function in middle - age in the Whitehall II study J. Clin Epidemiol 2005; 58: 1308-15.
- Forette F, Seux M-L, Staessen J.A et al. for the Syst-Eur Investigators. The Prevention of Dementia with Antihypertensive Treatment. New evidence from the Systolic Hypertension (Syst-Eur) Study. Arch Intern Med 2002; 162 (18): 2046-52.
- Lithell H, Hansson L, Skoog I et al; SCOPE Study Group. The study on cognition and prognosis in the elderly (SCOPE). Principal results of a randomised double - blind intervention trial. J Hypertens 2003; 21: 875-86.
- PROGRESS collaborative study group. Randomised trial of perindopril based blood pressure - lowering regimen among 6108 individuals with previous stroke or transient ischaemic attack. Lancet 2001; 358: 1033-41.
- Marpillat N.L, Macquin-Mavier I, Tropeano A-I et al. Antihypertensive classes, cognitive decline andincidence of dementia: a networkmeta - analysis. J Hypertens 2013, 31 (6): 1073-82.
- Chiu W-C, Ho W-C, Lin M-H et al; Health Data Analysis in Taiwan (hDATa) Research Group. Angiotension receptor blockers reduce the risk of dementia. J Hypertens 2014, 32: 938-47.
- The Progress Collaborative Group. Еffects of blood pressure lowering with perindopril and indapamade therapy on dementia and cognitive decline in patients with cerebrovascular disease. Arch Int Med 2003;163: 1069-75.
- Левин О.С., Дамулин И.В. Диффузные изменения белого вещества (лейкоареоз) и проблема сосудистой деменции. В кн.: Достижения в нейрогериатрии. Под ред. Н.Н.Яхно, И.В.Дамулина. Ч. 2. М., 1995; с. 189-231.
- Dufouil С, Chalmers J, Coskun O. Effects of blood pressure lowering on cerebral white matter hyperintensities in patients with stroke: the PROGRESS (Perindopril Protection Against Recurrent Stroke Study) Magnetic Resonance Imaging Substudy. Circulation 2005; 112 (1l): 1644-50.
- Остроумова О.Д., Десницкая И.В. Подходы к лечению артериальной гипертонии в условиях стационара: коррекция артериального давления и состояние когнитивных функций. // Системные гипертензии. 2005; 1 (2): 14-7.
- Морозова Т.Е., Гонтаренко С.В. Влияние антигипертензивных препаратов на состояние когнитивных функций у больных артериальной гипертензией I-II степени. Лечащий врач. 2014; 7: 15-9.
- Fogari R, Mugellini A, Zoppi A et al. Effects of valsartan compared with enalapril on blood pressure and cognitive function in elderly patients with essential hypertension. Eur. J Clin Pharmacol 2004; 59: 863-8.
- Sink К.М, Leng Х, Williamson J et al. Angiotensin Converting Enzyme Inhibitors and Cognitive Decline in Older Adults with Hypertension: Results from the Cardiovascular Health Study. Arch Intern Med 2009; 169 (13): 1195-202.
- Ohrui T, Tomita N, Sato-Nakagawa T et al. Effects of brain - penetrating ACE inhibitors on Alzheimer disease progression. Neurology 2004; 63: 1324-5.
- Pihlaja R, Kauppinen R, Koistinaho J, Koistinaho M. Multiple cellular and molecular mechanisms are involved in human Ab clearance by transplanted adult astrocytes. Glia 2011; 59 (11): 1643-57.
- Kehoe P.G, Wilcock G.K. Is inhibition of the renin - angiotensin system a new treatment option for Alzheimer’s disease? Lancet Neurol 2007; 6 (4): 373-8.
- Phillips M.I, de Oliveira E.M. Brain renin angiotensin in disease. J Mol Med 2008; 86 (6): 715-22.
- Ciobica A, Bild W, Hritcu L, Haulica I. Brain renin - angiotensin system in cognitive function: pre - clinical findings and implications for prevention and treatment of dementia. Acta Neurol Belg 2009; 109 (3): 171-80.
- Savaskan E, Hock C, Olivieri G et al. Cortical alterations of angiotensin converting enzyme, angiotensin II and AT1 receptor in Alzheimer’s dementia. Neurobiol Aging 2001; 22 (4): 541-6.
- Ferrari R, Pasanisi G, Notasrstefano P et al. Specific properties and effect of perindopril in controlling the renin - angiotensin system. Am J Hypertens 2005; 18: 142-54.